S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
Spotify sounding better to analysts as company tunes into profits
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
3 Reasons the Capital One-Discover merger is a big deal
How major US stock indexes fared Wednesday, 2/21/2024
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Range-bound Home Depot stock still is, lower prices ahead
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
Spotify sounding better to analysts as company tunes into profits
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
3 Reasons the Capital One-Discover merger is a big deal
How major US stock indexes fared Wednesday, 2/21/2024
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Range-bound Home Depot stock still is, lower prices ahead
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
Spotify sounding better to analysts as company tunes into profits
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
3 Reasons the Capital One-Discover merger is a big deal
How major US stock indexes fared Wednesday, 2/21/2024
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Range-bound Home Depot stock still is, lower prices ahead
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
Spotify sounding better to analysts as company tunes into profits
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
3 Reasons the Capital One-Discover merger is a big deal
How major US stock indexes fared Wednesday, 2/21/2024
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Range-bound Home Depot stock still is, lower prices ahead

Viking Therapeutics (VKTX) Short Interest Ratio & Short Volume

$35.18
-0.56 (-1.57%)
(As of 02/21/2024 ET)

Viking Therapeutics Short Interest Data

Current Short Volume
12,920,000 shares
Previous Short Volume
13,710,000 shares
Change Vs. Previous Month
-5.76%
Dollar Volume Sold Short
$311.89 million
Short Interest Ratio / Days to Cover
4.6
Last Record Date
January 31, 2024
Outstanding Shares
100,490,000 shares
Percentage of Shares Shorted
12.86%
Today's Trading Volume
2,672,443 shares
Average Trading Volume
3,609,679 shares
Today's Volume Vs. Average
74%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Viking Therapeutics ?

Sign up to receive the latest short interest report for Viking Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VKTX Short Interest Over Time

VKTX Days to Cover Over Time

VKTX Percentage of Float Shorted Over Time


Viking Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202412,920,000 shares $311.89 million -5.8%N/A4.6 $24.14
1/15/202413,710,000 shares $293.94 million +1.9%N/A5.3 $21.44
12/31/202313,460,000 shares $250.49 million -7.8%N/A5.3 $18.61
12/15/202314,600,000 shares $275.94 million -5.3%N/A5.9 $18.90
11/30/202315,420,000 shares $188.43 million -9.1%N/A6.4 $12.22
11/15/202316,970,000 shares $187.18 million +3.4%N/A8.5 $11.03
10/31/202316,420,000 shares $161.08 million +11.0%N/A8.6 $9.81
10/15/202314,800,000 shares $162.06 million +6.6%N/A7.7 $10.95
9/30/202313,890,000 shares $153.76 million +1.8%N/A7.8 $11.07
9/15/202313,640,000 shares $201.46 million +5.7%N/A6.6 $14.77
8/31/202312,910,000 shares $178.29 million -5.0%N/A5.6 $13.81
8/15/202313,590,000 shares $201.27 million +14.8%N/A5.5 $14.81
7/31/202311,840,000 shares $171.68 million -2.7%N/A4.2 $14.50
7/15/202312,170,000 shares $189.61 million +0.7%N/A4 $15.58
6/30/202312,090,000 shares $195.98 million +9.2%N/A3.6 $16.21
6/15/202311,070,000 shares $248.63 million -6.9%N/A2.2 $22.46
5/31/202311,890,000 shares $261.10 million -1.2%N/A2.5 $21.96
5/15/202312,030,000 shares $264.54 million +3.8%N/A2.5 $21.99
4/30/202311,590,000 shares $246.98 million +1.3%N/A2.6 $21.31
4/15/202311,440,000 shares $214.50 million +1.6%N/A2.7 $18.75
3/31/202311,260,000 shares $187.48 million +112.1%N/A2.9 $16.65
3/15/20235,310,000 shares $56.71 million +9.5%7.8%1.8 $10.68
2/28/20234,850,000 shares $53.40 million +4.1%7.1%1.3 $11.01
2/15/20234,660,000 shares $51.91 million +17.7%6.9%1.3 $11.14
1/31/20233,960,000 shares $34.69 million -33.2%5.9%1.1 $8.76
1/15/20235,930,000 shares $53.07 million +4.2%8.9%1.7 $8.95
12/30/20225,690,000 shares $53.49 million +201.1%8.4%1.7 $9.40
12/15/20221,890,000 shares $7.28 million +6.8%2.8%0.6 $3.85
11/30/20221,770,000 shares $7.17 million -1.7%2.6%2.3 $4.05
11/15/20221,800,000 shares $8.05 million -5.3%2.7%2.4 $4.47
10/31/20221,900,000 shares $7.79 million +6.2%2.8%2.9 $4.10
10/15/20221,790,000 shares $5.85 million -4.8%2.7%2.6 $3.27
9/30/20221,880,000 shares $5.11 million -2.6%2.8%3 $2.72
9/15/20221,930,000 shares $6.41 million -4.5%2.8%2.2 $3.32
8/31/20222,020,000 shares $6.42 million -3.4%3.0%2.1 $3.18
8/15/20222,090,000 shares $8.13 million -3.7%3.1%1.9 $3.89
7/31/20222,170,000 shares $0.00 -11.4%3.2%1.9 $0.00
7/15/20222,450,000 shares $9.07 million -9.6%3.6%2.2 $3.70
6/30/20222,710,000 shares $7.83 million -41.1%3.9%2.4 $2.89
6/15/20224,600,000 shares $9.98 million -1.9%6.7%4.4 $2.17













VKTX Short Interest - Frequently Asked Questions

What is Viking Therapeutics' current short interest?

Short interest is the volume of Viking Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 12,920,000 shares of VKTX short. Learn More on Viking Therapeutics' current short interest.

What is a good short interest ratio for Viking Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VKTX shares currently have a short interest ratio of 5.0. Learn More on Viking Therapeutics's short interest ratio.

Which institutional investors are shorting Viking Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Viking Therapeutics: GTS Securities LLC, Torno Capital LLC, Wolverine Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Viking Therapeutics' short interest increasing or decreasing?

Viking Therapeutics saw a drop in short interest in January. As of January 31st, there was short interest totaling 12,920,000 shares, a drop of 5.8% from the previous total of 13,710,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Viking Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Viking Therapeutics: Bausch Health Companies Inc. (5.96%), Xenon Pharmaceuticals Inc. (4.29%), Summit Therapeutics Inc. (1.61%), Rhythm Pharmaceuticals, Inc. (14.99%), IDEAYA Biosciences, Inc. (12.37%), Prestige Consumer Healthcare Inc. (3.51%), Arvinas, Inc. (13.57%), Amphastar Pharmaceuticals, Inc. (8.86%), Rocket Pharmaceuticals, Inc. (9.37%), MorphoSys AG (0.90%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Viking Therapeutics stock?

Short selling VKTX is an investing strategy that aims to generate trading profit from Viking Therapeutics as its price is falling. VKTX shares are trading down $0.56 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Viking Therapeutics?

A short squeeze for Viking Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VKTX, which in turn drives the price of the stock up even further.

How often is Viking Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VKTX, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:VKTX) was last updated on 2/22/2024 by MarketBeat.com Staff